MX2012008443A - Nucleosidos antiviricos. - Google Patents

Nucleosidos antiviricos.

Info

Publication number
MX2012008443A
MX2012008443A MX2012008443A MX2012008443A MX2012008443A MX 2012008443 A MX2012008443 A MX 2012008443A MX 2012008443 A MX2012008443 A MX 2012008443A MX 2012008443 A MX2012008443 A MX 2012008443A MX 2012008443 A MX2012008443 A MX 2012008443A
Authority
MX
Mexico
Prior art keywords
hcv
compunds
nucleosides
azido
hepatitis
Prior art date
Application number
MX2012008443A
Other languages
English (en)
Other versions
MX337050B (es
Inventor
David Bernard Smith
Keshab Sarma
Han Ma
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2012008443A publication Critical patent/MX2012008443A/es
Publication of MX337050B publication Critical patent/MX337050B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Compuestos que presentan la fórmula I, en la que R1, R2 y R3 son tal como se define en la presente memoria, inhibidores de la polimerasa NS5b del virus de la hepatitis C. También se dan a conocer composiciones y métodos para el tratamiento de una infección por VHC y para inhibir la replicación del VHC (Ver Formula).
MX2012008443A 2010-01-28 2011-01-25 Compuestos 4'-azido-nucleósidos como anti-vhc. MX337050B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29922910P 2010-01-28 2010-01-28
PCT/EP2011/050971 WO2011092158A1 (en) 2010-01-28 2011-01-25 4 ' - azido - nucleosides as anti - hcv compunds

Publications (2)

Publication Number Publication Date
MX2012008443A true MX2012008443A (es) 2012-08-15
MX337050B MX337050B (es) 2016-02-10

Family

ID=43587111

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012008443A MX337050B (es) 2010-01-28 2011-01-25 Compuestos 4'-azido-nucleósidos como anti-vhc.

Country Status (16)

Country Link
US (1) US8236779B2 (es)
EP (1) EP2528930B1 (es)
JP (1) JP5675849B2 (es)
KR (1) KR101384389B1 (es)
CN (1) CN102725303B (es)
BR (1) BR112012015951A2 (es)
CA (1) CA2784330C (es)
DK (1) DK2528930T3 (es)
ES (1) ES2437933T3 (es)
HK (1) HK1176938A1 (es)
MX (1) MX337050B (es)
PL (1) PL2528930T3 (es)
PT (1) PT2528930E (es)
RU (1) RU2556991C2 (es)
TW (1) TW201141488A (es)
WO (1) WO2011092158A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2701020T3 (es) * 2010-09-22 2019-02-20 Alios Biopharma Inc Nucleósidos azido y análogos nucleotídicos
EP2691409B1 (en) 2011-03-31 2018-02-21 Idenix Pharmaceuticals LLC. Compounds and pharmaceutical compositions for the treatment of viral infections
US9403863B2 (en) 2011-09-12 2016-08-02 Idenix Pharmaceuticals Llc Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
EP2768838A1 (en) 2011-10-14 2014-08-27 IDENIX Pharmaceuticals, Inc. Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
WO2013177195A1 (en) 2012-05-22 2013-11-28 Idenix Pharmaceuticals, Inc. 3',5'-cyclic phosphate prodrugs for hcv infection
AU2013266393B2 (en) 2012-05-22 2017-09-28 Idenix Pharmaceuticals Llc D-amino acid compounds for liver disease
US9109001B2 (en) 2012-05-22 2015-08-18 Idenix Pharmaceuticals, Inc. 3′,5′-cyclic phosphoramidate prodrugs for HCV infection
EA027929B1 (ru) 2012-05-25 2017-09-29 Янссен Сайенсиз Айрлэнд Юси Нуклеозиды на основе урацила и спирооксетана
EP2900682A1 (en) 2012-09-27 2015-08-05 IDENIX Pharmaceuticals, Inc. Esters and malonates of sate prodrugs
US10513534B2 (en) 2012-10-08 2019-12-24 Idenix Pharmaceuticals Llc 2′-chloro nucleoside analogs for HCV infection
US10723754B2 (en) 2012-10-22 2020-07-28 Idenix Pharmaceuticals Llc 2′,4′-bridged nucleosides for HCV infection
EP2935304A1 (en) 2012-12-19 2015-10-28 IDENIX Pharmaceuticals, Inc. 4'-fluoro nucleosides for the treatment of hcv
WO2014137930A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. Thiophosphate nucleosides for the treatment of hcv
EP2970358B1 (en) 2013-03-04 2021-06-30 Idenix Pharmaceuticals LLC 3'-deoxy nucleosides for the treatment of hcv
EP2970357A1 (en) 2013-03-13 2016-01-20 IDENIX Pharmaceuticals, Inc. Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
WO2014165542A1 (en) 2013-04-01 2014-10-09 Idenix Pharmaceuticals, Inc. 2',4'-fluoro nucleosides for the treatment of hcv
WO2014197578A1 (en) 2013-06-05 2014-12-11 Idenix Pharmaceuticals, Inc. 1',4'-thio nucleosides for the treatment of hcv
WO2015017713A1 (en) 2013-08-01 2015-02-05 Idenix Pharmaceuticals, Inc. D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
EP3131914B1 (en) 2014-04-16 2023-05-10 Idenix Pharmaceuticals LLC 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
CA2988393C (en) * 2014-06-13 2023-08-22 Ratiopharm Gmbh Solid state forms of sofosbuvir
RS62434B1 (sr) 2014-12-26 2021-11-30 Univ Emory Antivirusni n4-hidroksicitidin derivati
WO2016204531A1 (ko) * 2015-06-16 2016-12-22 엘지전자(주) 블록 경계에 따라 적응적으로 필터링을 수행하는 방법 및 장치
CN111372592A (zh) * 2017-12-07 2020-07-03 埃默里大学 N4-羟基胞苷及衍生物和与其相关的抗病毒用途
CN113880903B (zh) * 2021-09-23 2024-07-02 厦门蔚嘉制药有限公司 莫那比拉韦的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0110023A (pt) * 2000-04-13 2003-12-30 Pharmasset Ltd Derivados de nucleosìdeo 3'-ou-2' substituìdos para tratamento de infecções por vìrus da hepatite
EP1411954B1 (en) * 2000-10-18 2010-12-15 Pharmasset, Inc. Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
EP1539188B1 (en) * 2001-01-22 2015-01-07 Merck Sharp & Dohme Corp. Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
GB0114286D0 (en) * 2001-06-12 2001-08-01 Hoffmann La Roche Nucleoside Derivatives
KR20050006221A (ko) * 2002-05-06 2005-01-15 제네랩스 테크놀로지스, 인코포레이티드 Ｃ형 간염 바이러스 감염 치료용의 뉴클레오시드 유도체
TWI332507B (en) * 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
CN100351264C (zh) * 2002-11-19 2007-11-28 霍夫曼-拉罗奇有限公司 抗病毒核苷衍生物
PL1962808T3 (pl) * 2005-12-14 2011-03-31 Hoffmann La Roche Preparat proleku przeciw HCV
US20090318380A1 (en) * 2007-11-20 2009-12-24 Pharmasset, Inc. 2',4'-substituted nucleosides as antiviral agents
AR069740A1 (es) * 2007-11-29 2010-02-17 Metabasis Therapeutics Inc Compuestos nucleosidos antivirales

Also Published As

Publication number Publication date
US8236779B2 (en) 2012-08-07
CA2784330A1 (en) 2011-08-04
ES2437933T3 (es) 2014-01-15
CN102725303A (zh) 2012-10-10
KR101384389B1 (ko) 2014-04-10
HK1176938A1 (en) 2013-08-09
RU2556991C2 (ru) 2015-07-20
PL2528930T3 (pl) 2014-03-31
CA2784330C (en) 2018-02-13
CN102725303B (zh) 2015-05-27
WO2011092158A1 (en) 2011-08-04
JP5675849B2 (ja) 2015-02-25
RU2012136379A (ru) 2014-03-10
EP2528930A1 (en) 2012-12-05
BR112012015951A2 (pt) 2018-10-16
EP2528930B1 (en) 2013-10-30
DK2528930T3 (da) 2013-11-11
MX337050B (es) 2016-02-10
TW201141488A (en) 2011-12-01
KR20120110177A (ko) 2012-10-09
PT2528930E (pt) 2013-11-26
US20110150829A1 (en) 2011-06-23
JP2013518076A (ja) 2013-05-20

Similar Documents

Publication Publication Date Title
MX2012008443A (es) Nucleosidos antiviricos.
MX2012003170A (es) Compuestos heterociclicos antivirales.
MX2010004623A (es) Compuestos heterociclicos antiviricos.
MX2009008872A (es) Compuestos macrociclicos como inhibidores de proteasa ns3 del virus de hepatitis c.
MY152070A (en) Macrocyclic quinxaline compounds as hcv ns3 protease inhibitors
MY157435A (en) Heterocyclic antiviral compounds
SI1987038T1 (sl) Hcv ns5b inhibitorji
MX2009004888A (es) Inhibidores del virus de la hepatitis c.
HK1128131A1 (en) Hepatitis c virus inhibitors
TW200745120A (en) Indolobenzazepine HCV NS5B inhibitors
MX2011009644A (es) Inhibidores del virus de la hepatitis c.
TW200745151A (en) Antiviral nucleosides
MX2012000959A (es) Inhibidores de los virus flaviviridae.
WO2009069095A3 (en) Antiviral nucleoside compounds
MX2009009473A (es) Compuestos para el tratamiento de hepatitis c.
MX2012004032A (es) Compuestos para el tratamiento de hepatitis c.
MX2011006631A (es) Inhibidores de proteasa ns3 del virus hcv.
MX2010005226A (es) Inhibidores de ns5b de hcv de indolobenzazepina fusionados a ciclopropilo.
MX2011012541A (es) Compuestos heterociclicos antivirales.
MX2012006513A (es) Compuestos heterociclicos antivirales.
MX2010001416A (es) Compuesto para el tratamiento de la hepatitis c.
WO2012019299A9 (en) Hepatitis c inhibitor compounds
MX2011011112A (es) Compuestos antivirales heterociclicos.
MX2011012240A (es) Compuestos heterociclicos antivirales.
MX2010010061A (es) Compuestos para el tratamiento de hepatitis c.

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: RIBOSCIENCE LLC

FG Grant or registration